Identification of Response Predictors to Capecitabine/Temozolomide in Metastatic Pancreatic Neuroendocrine Tumors

被引：0
|
作者：
Cives, Mauro [1 ]
Ghayouri, Masoumeh [1 ]
Brelsford, Marjorie [1 ]
Black, Michael [1 ]
Rizzo, Anthony [2 ]
Meeker, Alan [2 ]
Strosberg, Jonathan [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
来源：
PANCREAS | 2016年 / 45卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：473 / 474
页数：2
相关论文
共 50 条
  • [31] Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)
    Kunz, Pamela T.
    Graham, Noah T.
    Catalano, Paul J.
    Nimeiri, Halla S.
    Fisher, George A.
    Longacre, Teri A.
    Suarez, Carlos J.
    Martin, Brock A.
    Yao, James C.
    Kulke, Matthew H.
    Hendifar, Andrew E.
    Shanks, James C.
    Shah, Manisha H.
    Zalupski, Mark M.
    Schmulbach, Edmond L.
    Reidy-Lagunes, Diane L.
    Strosberg, Jonathan R.
    O'Dwyer, Peter J.
    Benson, Al B., III
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (07) : 1359 - +
  • [32] Exceptional response to neoadjuvant capecitabine and temozolomide in TSC2-mutant pancreatic neuroendocrine tumor
    Park, Robin
    Chatterjee, Deyali
    Amin, Manik
    Trikalinos, Nikolaos A.
    CURRENT PROBLEMS IN CANCER: CASE REPORTS, 2020, 2
  • [33] Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor
    de Mestier, Louis
    Walter, Thomas
    Evrard, Camille
    de Boissieu, Paul
    Hentic, Olivia
    Cros, Jerome
    Tougeron, David
    Lombard-Bohas, Catherine
    Rebours, Vinciane
    Hammel, Pascal
    Ruszniewski, Philippe
    NEUROENDOCRINOLOGY, 2020, 110 (1-2) : 83 - 91
  • [34] The efficacy of capecitabine and temozolomide for the treatment of metastatic neuroendocrine tumors: Memorial Sloan-Kettering Cancer Center experience
    Ganetsky, Alex
    Adel, Nelly G.
    Do, Kinh Gian
    Reidy, Diane Lauren
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [35] Temozolomide and thalidomide effective in treating metastatic neuroendocrine tumors
    Heath V.
    Nature Clinical Practice Endocrinology & Metabolism, 2006, 2 (5): : 247 - 247
  • [36] Temozolomide and thalidomide effective in treating metastatic neuroendocrine tumors
    Vicky Heath
    Nature Clinical Practice Urology, 2006, 3 (5): : 245 - 245
  • [37] Therapy for metastatic pancreatic neuroendocrine tumors
    Rossi, Roberta Elisa
    Massironi, Sara
    Conte, Dario
    Peracchi, Maddalena
    ANNALS OF TRANSLATIONAL MEDICINE, 2014, 2 (01)
  • [38] Effective Treatment of a Metastatic Thymic Neuroendocrine Tumor with Capecitabine and Temozolomide: A Case Report
    SarangaPerry, V
    Morse, B.
    Kvols, L.
    Strosberg, J.
    NEUROENDOCRINOLOGY, 2012, 96 : 58 - 58
  • [39] Efficacy of Oral Chemotherapy with Capecitabine and Temozolomide (Captem) in Patients with Metastatic Neuroendocrine Tumors (NETS). A Single-Institution Experience
    Smiroldo, V
    Carnaghi, C.
    Lania, A.
    Bonifacio, C.
    Pepe, G.
    Zerbi, A.
    Rimassa, L.
    Lavezzi, E.
    Spaggiari, P.
    NEUROENDOCRINOLOGY, 2018, 106 : 206 - 206
  • [40] Prospective phase II study of capecitabine and temozolomide (CAPTEM) for progressive, moderately, and well-differentiated metastatic neuroendocrine tumors
    Fine, Robert Lance
    Gulati, Anthony Paul
    Tsushima, Dawn
    Mowatt, Kelley B.
    Oprescu, Anna
    Bruce, Jeffrey N.
    Chabot, John A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
12345